EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
+65.56%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$472M
AUM Growth
–
Cap. Flow
+$472M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
10
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
PMV Pharmaceuticals
PMVP
|
$257M |
| 2 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$63.1M |
| 3 |
Oric Pharmaceuticals
ORIC
|
$47.4M |
| 4 |
Denali Therapeutics
DNLI
|
$27.1M |
| 5 |
Foghorn Therapeutics
FHTX
|
$25.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.36% |
| 2 | Financials | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PMV Pharmaceuticals
PMVP
$74.2M
| $257M | 54.42% |
+4,179,416
| New | +$257M |
|
|
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $63.1M | 13.37% |
+2,083,602
| New | +$63.1M |
|
|
3
Oric Pharmaceuticals
ORIC
$994M
| $47.4M | 10.04% |
+1,400,435
| New | +$47.4M |
|
|
4
Denali Therapeutics
DNLI
$2.23B
| $27.1M | 5.74% |
+323,749
| New | +$27.1M |
|
|
5
Foghorn Therapeutics
FHTX
$286M
| $25.6M | 5.41% |
+1,261,261
| New | +$25.6M |
|
|
CNST
6
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $16M | 3.38% |
+554,325
| New | +$16M |
|
7
Alector
ALEC
$238M
| $14.8M | 3.14% |
+980,894
| New | +$14.8M |
|
8
RAPT Therapeutics
RAPT
$188M
| $14.5M | 3.08% |
+735,801
| New | +$14.5M |
|
9
Revolution Medicines
RVMD
$7.1B
| $3.7M | 0.78% |
+93,436
| New | +$3.7M |
|
10
First Financial Bancorp
FFBC
$2.51B
| $3.04M | 0.64% |
+173,576
| New | +$3.04M |
|